Diagnostic Breakthroughs for Neurodegenerative Diseases

Diagnostic Breakthroughs for Neurodegenerative Diseases

R&D on Overdrive to Address Intensifying Disease Burden, Neuroimaging Technologies to Remain Gold-standard for Neurodiagnostic Applications

RELEASE DATE
30-Mar-2016
REGION
Global
Research Code: D6BC-01-00-00-00
SKU: LS00155-GL-TR_17039
AvailableYesPDF Download

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
LS00155-GL-TR_17039

$4,950.00

$3,712.50save 25 %

DownloadLink
ENQUIRE NOW

Description

This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic markets. The research service also includes drivers & challenges, market adoption, collaborations, funding and patent scenarios for neurodiagnostic technologies.

Table of Contents

1.1 Scope of Research

1.2 Research Methodology

1.2 Research Methodology (continued)

1.3 Key Findings

2.1 Overview of Neurodegenerative Diseases

2.2 Neurodegenerative Disease Diagnostics – Segmentation

2.3 Biomarker-based Diagnostics: Overview

2.3.1 Key Biomarkers for Neurodiagnostics

2.3.2 Emerging Biomarker Diagnostics for MCI, AD, TBI, PD and Dementia

2.3.3 Emerging Biomarker Diagnostics for ALS, FTD, TBI and AD

2.4 Neuroimaging Technologies: Overview

2.4.1 Neuroimaging Technologies

2.4.2 Neuroimaging Technologies

2.4.3 Neuroimaging Technologies

2.4.4 Neuroimaging Technologies: Innovation Ecosystems

2.5 Neuroinformatics: Overview

2.6 Neuroinformatics: Innovation Ecosystems

3.1 Venture Investment Scenario for Neurobiomarkers

3.2 Public Funding Landscape for Neurobiomarker Projects

3.3 Summary of Key Public Funding Trends for Neurobiomarker Projects

4.1 Key Technological Drivers and Challenges Across Neurodiagnostic Markets

4.1.1 Key Technologies Driving the Growth of Global Neurodiagnostic Markets

4.1.2 Technological Challenges Across the Neurodiagnostic Sector

4.2 Overview of Key Market Drivers and Challenges Across the Neurodiagnostic Sector

4.2.1 Key Market Drivers Fueling the Growth of the Global Neurodiagnostic Sector

4.2.2 Key Market Challenges Impeding the Advancements of Neurodiagnostics

4.3 Clinical Trials Analysis for Neuroimaging Markets in the US

4.4 Adoption Scenario for Biomarker Diagnostics

4.5 Adoption Scenario for Neuroimaging Techniques

4.6 Adoption Scenario for Neuroinformatic Tools

5.1 Overview of the Collaborative Landscape Across Neurodiagnostic Markets

5.2 Product Development Partnerships – Diagnostics

5.3 Product Development Partnerships – Companion Diagnostics

5.4 Licensing and Research Collaborations – Neurodiagnostics

5.5 Research Consortia Across Global Neurodiagnostic Markets

5.6 Emerging Technologies in Neurodiagnostics

5.7 Conclusions

6.1 Patent Search Scope

6.2 Patents for Neurodegenerative Diseases – Timeline Overview

6.3 Global Patent Spread by Assignees

6.4 Global Patent Spread by Patent Offices

7.1 Key Contacts

7.2 Appendix I

7.2 Appendix I

7.3 Appendix II

Legal Disclaimer

8.1 The Frost & Sullivan Story

8.2 Value Proposition: Future of Your Company & Career

8.3 Global Perspective

8.4 Industry Convergence

8.5 360º Research Perspective

8.6 Implementation Excellence

8.7 Our Blue Ocean Strategy

This research service covers key technological trends and developments in diagnostics for neurodegenerative diseases, which are likely to have a high impact in the near future. The technologies present across the global neurodiagnostic industry have been covered under neurobiomarkers, neuroimaging and neuroinformatics segments. While providing brief overviews for each technology, the research service also covers industrial snapshots and emerging innovations in the neurodiagnostic markets. The research service also includes drivers & challenges, market adoption, collaborations, funding and patent scenarios for neurodiagnostic technologies.
More Information
No Index No
Podcast No
Author Vandana Iyer
WIP Number D6BC-01-00-00-00
Is Prebook No